Find Out How to Combine HRMS With ELISA to Quickly Solve HCP Challenges The process of producing recombinant proteins — such as gene therapies, cell-based therapies, or vaccines — utilizes cells to biosynthesize the desired therapeutic molecules. The production of these therapies involves genetically altering the cells to produce the desired therapeutic protein, which is …
Learn more in our case study on how we used our advanced HRMS capabilities, detailed analytical outputs, and close, transparent communication to quickly identify high-risk proteins and advise process changes to de-risk a client’s biotherapeutic. Read the Case Study Now:
Choosing the right bioanalytical CRO partner is one of the most important decisions you’ll make in the development of your drug. For comprehensive characterization that enables you to make your biggest decisions with confidence, go with the pro — Prolytix. Download Now:
